YiChang HEC ChangJiang Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 202.246 million compared to CNY 2,083.705 million a year ago. Operating loss was CNY 468.906 million compared to operating Income of CNY 880.900 million a year ago. Net loss was CNY 507.028 million compared to net income of CNY 617.508 million a year ago.